Progressive pulmonary fibrosis: an expert group consensus statement
European Respiratory Journal · 2023-03 · 61 (3) · 2103187
DOI: 10.1183/13993003.03187-2021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 14.12.2022. Verfasst von Sujeet K Rajan und 21 weiteren Autor:innen. Beteiligte Einrichtung: Bombay Hospital Institute of Medical Sciences and Bhatia Hospital, Mumbai, India skrajan@hotmail.com. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 261-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Versus Arthritis.
Abstract (Originalsprache)
This expert group consensus statement emphasises the need for standardising the definition of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis being of paramount importance in ensuring appropriate initial management. Equally, case-by-case decisions on monitoring and management are essential, given the varying presentations of F-ILDs and the varying rates of progression. The value of diagnostic tests in risk stratification at presentation and, separately, the importance of a logical monitoring strategy, tailored to manage the risk of progression, are also stressed. The term “progressive pulmonary fibrosis” (PPF) exactly describes the entity that clinicians often face in practice. The importance of using antifibrotic therapy early in PPF (once initial management has failed to prevent progression) is increasingly supported by evidence. Artificial intelligence software for high-resolution computed tomography analysis, although an exciting tool for the future, awaits validation. Guidance is provided on pulmonary rehabilitation, oxygen and the use of non-invasive ventilation focused specifically on the needs of ILD patients with progressive disease. PPF should be differentiated from acute deterioration due to drug-induced lung toxicity or other forms of acute exacerbations. Referral criteria for a lung transplant are discussed and applied to patient needs in severe diseases where transplantation is not realistic, either due to access limitations or transplantation contraindications. In conclusion, expert group consensus guidance is provided on the diagnosis, treatment and monitoring of F-ILDs with specific focus on the recognition of PPF and the management of pulmonary fibrosis progressing despite initial management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Bombay Hospital Institute of Medical Sciences and Bhatia Hospital, Mumbai, India skrajan@hotmail.com.
- National French Reference Coordinating Center for Rare Pulmonary Diseases, Louis Pradel Hospital Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INRAE, Member of ERN-LUNG, Lyon, France.
- CK Birla Hospitals, Kolkata, India.
- Johns Hopkins School of Medicine, Baltimore, MD, USA.
- University of Michigan, Ann Arbor, MI, USA.
- Department of Medicine, National Jewish Health, Denver, CO, USA.
ORCID-Profile: Sujeet K Rajan, Vincent Cottin, Sahajal Dhooria, Martin Kolb
Förderung
- Versus Arthritis
Zitieren
APA
Rajan, S. K., Cottin, V., Dhar, R., Danoff, S., Flaherty, K. R., Brown, K. K., Mohan, A., Renzoni, E., Mohan, M., Udwadia, Z., Shenoy, P., Currow, D., Devraj, A., Jankharia, B., Kulshrestha, R., Jones, S., Ravaglia, C., Quadrelli, S., Iyer, R., …, & Wells, A. U. (2023). Progressive pulmonary fibrosis: an expert group consensus statement. European Respiratory Journal, 61(3), 2103187. https://doi.org/10.1183/13993003.03187-2021
Vancouver
Rajan SK, Cottin V, Dhar R, Danoff S, Flaherty KR, Brown KK, et al. Progressive pulmonary fibrosis: an expert group consensus statement. European Respiratory Journal. 2023;61(3):2103187. doi:10.1183/13993003.03187-2021
BibTeX
@article{Rajan2023,
author = {Rajan, Sujeet K and Cottin, Vincent and Dhar, Raja and Danoff, Sonye and Flaherty, Kevin R and Brown, Kevin K and Mohan, Anant and Renzoni, Elizabeth and Mohan, Murali and Udwadia, Zarir and Shenoy, Padmanabha and Currow, David and Devraj, Anand and Jankharia, Bhavin and Kulshrestha, Ritu and Jones, Steve and Ravaglia, Claudia and Quadrelli, Silvia and Iyer, Rajam and Dhooria, Sahajal and Kolb, Martin and Wells, Athol U},
title = {Progressive pulmonary fibrosis: an expert group consensus statement},
journal = {European Respiratory Journal},
year = {2023},
volume = {61},
number = {3},
pages = {2103187},
doi = {10.1183/13993003.03187-2021}
}
EUVIMED